GO:1990414 replication-born double-strand break repair via sister chromatid exchange

Replication-born double-strand breaks (DSBs) are a particularly dangerous form of DNA damage because they arise when a replication fork encounters a single-strand break or a bulky lesion, leading to fork collapse. The repair of these breaks is essential for maintaining genomic integrity, and cells have evolved specialized pathways to handle them. One such pathway is replication-born double-strand break repair via sister chromatid exchange (SCE), which uses the newly synthesized sister chromatid as a template for accurate repair. This process is a form of homologous recombination that is tightly coupled to DNA replication and is critical for preventing chromosomal instability. Understanding the molecular mechanisms of replication-born DSB repair via SCE is important for basic research and for understanding how defects in this pathway contribute to human diseases, including cancer. The pathway involves a complex interplay of recombination proteins and structure-specific nucleases that process recombination intermediates to ensure proper repair. Recent studies have begun to dissect the distinct roles of these nucleases, such as Mus81, Yen1, Slx1-Slx4, and Rad1, in this specific repair context. This article provides a comprehensive overview of GO:1990414, covering its definition, biological significance, key genes, regulatory aspects, disease associations, and the experimental models and methods used to study it. By integrating authoritative Gene Ontology data with published literature, we aim to support researchers in designing experiments and interpreting results related to this critical DNA repair pathway.

GO:1990414, replication-born double-strand break repair via sister chromatid exchange, is defined as the repair of a double-strand DNA break that originates during DNA replication, where the DNA molecule is repaired using the homologous sequence of the sister chromatid as a template. This process ensures that the genetic information lost at the break site is accurately restored, preventing mutations and chromosomal rearrangements.

Replication-born double-strand breaks are a major source of genomic instability if left unrepaired or repaired incorrectly. The sister chromatid exchange pathway provides an error-free repair mechanism that is essential for maintaining genome integrity during DNA replication. Defects in this pathway can lead to chromosomal translocations, loss of heterozygosity, and cancer development. Therefore, understanding the molecular details of this repair process is crucial for identifying therapeutic targets and for understanding the etiology of diseases characterized by genome instability.

The following genes and proteins are key players in replication-born double-strand break repair via sister chromatid exchange, as identified in published literature.

The repair of replication-born double-strand breaks via sister chromatid exchange is regulated at multiple levels, including cell cycle-dependent expression and post-translational modifications of key factors. For example, the activity of the Yen1 nuclease is regulated by cell cycle-dependent phosphorylation and nuclear localization, ensuring that it acts at the appropriate time. Additionally, the choice between different subpathways of homologous recombination is influenced by the availability of sister chromatids, which is restricted to S and G2 phases of the cell cycle. The coordination of nucleases such as Mus81, Yen1, Slx1-Slx4, and Rad1 is also subject to regulation to prevent inappropriate processing of recombination intermediates.

Defects in the repair of replication-born double-strand breaks via sister chromatid exchange can lead to genomic instability, a hallmark of cancer. Loss of function of nucleases involved in this pathway, such as Mus81 or Yen1, can result in increased chromosomal rearrangements and sensitivity to DNA-damaging agents. In human cells, mutations in homologous recombination genes, including those in the Fanconi anemia pathway, are associated with cancer predisposition. Understanding the specific contributions of replication-born DSB repair by SCE to tumorigenesis may reveal new therapeutic targets.

Tumors with defects in homologous recombination, including replication-born DSB repair by SCE, may be sensitive to poly(ADP-ribose) polymerase (PARP) inhibitors due to synthetic lethality. Conversely, upregulation of this repair pathway can contribute to resistance to chemotherapy agents that induce replication stress. Targeting the nucleases involved in this pathway, such as Mus81, could sensitize cancer cells to DNA-damaging therapies.

Impaired repair of replication-born DSBs has been linked to developmental disorders characterized by growth retardation and neurological defects. In model organisms, mutations in genes required for this repair pathway can cause sensitivity to replication stress and reduced lifespan. The accumulation of unrepaired replication-born DSBs may contribute to aging and age-related diseases.

Sister chromatid exchange assays, such as the differential staining of sister chromatids with BrdU, are classic methods to measure homologous recombination repair. These assays can be adapted to specifically monitor replication-born DSB repair by inducing site-specific breaks and quantifying SCE events. In yeast, genetic assays such as the direct repeat recombination assay can measure SCE frequency.

Fluorescence microscopy can visualize the recruitment of repair factors to sites of replication-born DSBs. Live-cell imaging of fluorescently tagged proteins, such as Rad51 or Mus81, allows real-time monitoring of their dynamics at damage sites. These techniques are valuable for understanding the spatiotemporal regulation of the repair process.

ChIP followed by quantitative PCR or sequencing can determine the binding of repair proteins to specific genomic loci during replication-born DSB repair. This method provides insights into the recruitment kinetics and stoichiometry of factors at break sites. It can also be used to map recombination intermediates genome-wide.

CRISPR knockout or interference screens can identify genes that are essential for replication-born DSB repair by SCE. By using reporter systems that measure SCE or cell survival after replication stress, researchers can uncover novel components of this pathway. These screens are powerful for unbiased discovery of repair factors.

Researchers studying replication-born double-strand break repair via sister chromatid exchange-related genes often need to determine whether a candidate gene is causally involved in this pathway or merely correlated with its activity. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies, from gene knockout to precise point mutations and knock-in models, as well as library screening and bioinformatics support.

Replication-born double-strand break repair via sister chromatid exchange (GO:1990414) is a critical homologous recombination subpathway that safeguards genome integrity during DNA replication. The coordinated action of structure-specific nucleases and recombination factors ensures accurate repair and prevents chromosomal instability. Defects in this pathway contribute to cancer and other diseases, making it an attractive target for therapeutic intervention. Continued research using advanced CRISPR models and functional assays will further elucidate the molecular details and disease relevance of this process.